Black Diamond Therapeutics Inc.

BDTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.95

-$0.01 (-0.51%)

At close: Sep 21, 2026, 4:00 PM ET

$1.96

+$0.01 (+0.51%)

After-hours: Sep 21, 2026, 7:44 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $112.31M

Enterprise Value $18.2M

Beta 3.31

Average Volume 1.37M

Shares Outstanding (Diluted) 57.37M

Shares Change YoY 0.99%

Institutional Ownership 67.29%

Exchange NASDAQ

ISIN US09203E1055

Price Performance

Price Change 1M -11.8%

Price Change 3M 21.1%

Price Change 6M -11.0%

Price Change YTD -21.7%

Price Change 1Y -43.0%

Price Change 3Y -42.8%

Price Change 5Y -79.0%

1M CAGR (ann.) 2.1%

1Y CAGR (ann.) -38.0%

5Y CAGR (ann.) -27.6%

All-Time CAGR -36.4%

Valuation

PE Ratio -2.64

Forward PE N/A

PEG Ratio 0.01

Forward PEG -0.05

PS Ratio N/A

Forward PS 39.30

PB Ratio 1.16

P/FCF Ratio -3.49

P/Adj. FCF Ratio -2.93

P/OCF Ratio -3.48

EV/Sales N/A

EV/EBIT -0.44

EV/EBITDA -0.45

EV/FCF -0.57

Earnings Yield -38.0%

FCF Yield -28.6%

Adj. FCF Yield -34.1%

Financial Health

Net Cash $110.51M

Total Debt $16.97M

Cash & Short-Term Investments $110.51M

Total Assets $125.03M

Current Ratio 7.28

Quick Ratio 7.28

Debt / Equity Ratio 0.18

Debt / EBITDA -0.42

Debt / FCF -0.53

OCF / Debt -1.89

Interest Coverage 0.00

Altman Z-Score -3.22

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -19.1%

Returns

Return on Assets -34.0%

Return on Equity -38.8%

Return on Invested Capital -45.9%

Return on Capital Employed -47.5%

Return on Tangible Assets -34.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 0.0%

Revenue CAGR 5Y 50.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 59.9%

EPS CAGR 5Y 47.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y 47.7%

FCF CAGR 5Y 47.0%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 11

EPS Growth Next 3Y -9.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.06

EPS Growth Est (next Q) -63.3%

Revenue Est (next Q) $8.33M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $11.83

Price Target Upside 506.7%

Cash Flow

Operating Cash Flow $-32.01M

Free Cash Flow $-32.01M

Adj. Free Cash Flow $-38.12M

FCF Per Share -$0.56

OCF Per Share -$0.56

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-27K

Operating Income $-51.9M

EBITDA $-40.88M

Net Income $-42.56M

EPS (Diluted) -$0.74

Revenue / Employee N/A

Profit / Employee $-2.03M

Employees 21